Exploring Gene Therapy for Myelin Repair in Multiple Sclerosis

Wednesday, 18 September 2024, 04:44

Multiple sclerosis research has received a $1 million grant to investigate gene therapy targeting myelin repair. Dr. Isabel Pérez-Otaño's lab will focus on understanding brain nerve mechanisms and gene interactions vital for repairing sclerosis damage.
LivaRava_Medicine_Default.png
Exploring Gene Therapy for Myelin Repair in Multiple Sclerosis

Funding for Myelin Repair Research

The National Multiple Sclerosis Society (USA) has awarded a grant of 1 million dollars to Dr. Isabel Pérez-Otaño, who leads the Plasticity and Remodeling of Neural Circuits laboratory at the Institute. This funding aims to support innovative research on myelin repair mechanisms in multiple sclerosis.

Significance of Myelin Repair

Myelin, a protective sheath around nerve fibers, plays a crucial role in the brain's functionality. Research indicates that repairing myelin can significantly improve nerve signaling and recovery in multiple sclerosis patients.

Research Objectives

  1. Investigate gene therapy options to enhance myelin repair.
  2. Understand the molecular mechanisms involved in sclerosis.
  3. Explore the role of specific genes in nerve regeneration.

This study aims to pave the way for novel treatment approaches in multiple sclerosis.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe